MX2020012035A - Novedoso modulador de receptores metabotrópicos e ionotrópicos transmembrana y uso del mismo. - Google Patents
Novedoso modulador de receptores metabotrópicos e ionotrópicos transmembrana y uso del mismo.Info
- Publication number
- MX2020012035A MX2020012035A MX2020012035A MX2020012035A MX2020012035A MX 2020012035 A MX2020012035 A MX 2020012035A MX 2020012035 A MX2020012035 A MX 2020012035A MX 2020012035 A MX2020012035 A MX 2020012035A MX 2020012035 A MX2020012035 A MX 2020012035A
- Authority
- MX
- Mexico
- Prior art keywords
- diseases
- compound
- receptors
- trpv1
- ion channels
- Prior art date
Links
- 230000001057 ionotropic effect Effects 0.000 title 1
- 102000027257 transmembrane receptors Human genes 0.000 title 1
- 108091008578 transmembrane receptors Proteins 0.000 title 1
- 208000011231 Crohn disease Diseases 0.000 abstract 2
- 102000004310 Ion Channels Human genes 0.000 abstract 2
- 102000003840 Opioid Receptors Human genes 0.000 abstract 2
- 108090000137 Opioid Receptors Proteins 0.000 abstract 2
- 102000003610 TRPM8 Human genes 0.000 abstract 2
- 102000003566 TRPV1 Human genes 0.000 abstract 2
- 102000007124 Tachykinin Receptors Human genes 0.000 abstract 2
- 108010072901 Tachykinin Receptors Proteins 0.000 abstract 2
- 101150111302 Trpm8 gene Proteins 0.000 abstract 2
- 101150016206 Trpv1 gene Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- -1 2-phenylethylamide N-(p-hydroxyphenylacetyl)phenylalanine compound Chemical class 0.000 abstract 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 206010006458 Bronchitis chronic Diseases 0.000 abstract 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 206010011224 Cough Diseases 0.000 abstract 1
- 208000014997 Crohn colitis Diseases 0.000 abstract 1
- 206010012438 Dermatitis atopic Diseases 0.000 abstract 1
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 208000003251 Pruritus Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 208000018569 Respiratory Tract disease Diseases 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 201000008937 atopic dermatitis Diseases 0.000 abstract 1
- 206010006451 bronchitis Diseases 0.000 abstract 1
- 208000007451 chronic bronchitis Diseases 0.000 abstract 1
- 201000009151 chronic rhinitis Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 206010039083 rhinitis Diseases 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La invención se refiere a la química orgánica, farmacología y medicina, y se refiere al tratamiento de enfermedades inflamatorias y autoinmunes, tales como psoriasis, dermatitis atópica, prurigo, enfermedad de Crohn, colitis, enfermedades gastrointestinales tales como diarrea y síndrome del intestino irritable, enfermedades respiratorias tales como asma, COPD, bronquitis, rinitis, y también tos y una serie de otras enfermedades asociadas con la actividad de receptores opioides y de taquiquinina y de canales de iones TRPV1 y TRPM8, usando un compuesto de 2-feniletilamina N-(p-hidroxifenilacetil)fenilalanina ; (ver fórmula) la invención, y también aductos farmacéuticamente aceptables, hidratos, solvatos, son agonistas de receptores opioides, agonistas de receptores de taquiquinina y de canales de iones TRPV1 y TRPM8; la invención también se refiere a composiciones farmacéuticas que comprenden una cantidad terapéuticamente efectiva del compuesto de acuerdo con la invención.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2018117463A RU2697414C1 (ru) | 2018-05-11 | 2018-05-11 | Новый антагонист тахикининовых рецепторов и его применение |
| PCT/RU2019/050060 WO2019216795A1 (ru) | 2018-05-11 | 2019-05-07 | Новый модулятор метаботропных и ионотропных трансмембранных рецепторов и его применение |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020012035A true MX2020012035A (es) | 2021-03-29 |
Family
ID=67640490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020012035A MX2020012035A (es) | 2018-05-11 | 2019-05-07 | Novedoso modulador de receptores metabotrópicos e ionotrópicos transmembrana y uso del mismo. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US11414377B2 (es) |
| EP (1) | EP3792247A4 (es) |
| JP (1) | JP7301954B2 (es) |
| KR (1) | KR20210008061A (es) |
| CN (1) | CN112384495B (es) |
| AU (1) | AU2019267188B2 (es) |
| CA (1) | CA3099849A1 (es) |
| CL (1) | CL2020002908A1 (es) |
| CU (1) | CU24662B1 (es) |
| EA (1) | EA202092712A1 (es) |
| GE (1) | GEP20237454B (es) |
| IL (1) | IL278603B2 (es) |
| MA (1) | MA52582A (es) |
| MX (1) | MX2020012035A (es) |
| PH (1) | PH12020551928A1 (es) |
| RU (1) | RU2697414C1 (es) |
| SG (1) | SG11202011189TA (es) |
| WO (1) | WO2019216795A1 (es) |
| ZA (1) | ZA202007027B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2697414C1 (ru) * | 2018-05-11 | 2019-08-14 | Общество с ограниченной ответственностью "АЙ БИ ДИ Терапевтикс" | Новый антагонист тахикининовых рецепторов и его применение |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4579841A (en) * | 1981-07-20 | 1986-04-01 | University Patents, Inc. | Dipeptide derivatives having opiate activity |
| US5610145A (en) * | 1994-04-15 | 1997-03-11 | Warner-Lambert Company | Tachykinin antagonists |
| CZ288345B6 (en) * | 1995-02-22 | 2001-05-16 | Novartis Ag | Arylacylaminoethanes, process of their preparation and pharmaceutical preparation in which they are comprised |
| MY132550A (en) * | 1996-08-22 | 2007-10-31 | Novartis Ag | Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists |
| GB9907571D0 (en) | 1999-04-06 | 1999-05-26 | Zeneca Ltd | Compounds |
| EP1276729B1 (en) | 2000-04-06 | 2008-07-09 | AstraZeneca AB | New neurokinin antagonists for use as medicaments |
| DE60114597T2 (de) | 2000-04-06 | 2006-07-20 | Astrazeneca Ab | Naphthamid-neurokinin antagonisten zur verwendung als medikamente |
| SE0003476D0 (sv) | 2000-09-28 | 2000-09-28 | Astrazeneca Ab | Compounds |
| EP1295599A1 (en) | 2001-09-21 | 2003-03-26 | Boehringer Ingelheim International GmbH | Method for the treatment of prevention of atopic dermatitis |
| RU2309144C2 (ru) * | 2005-03-25 | 2007-10-27 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Фенилсодержащие n-ацильные производные аминов, способ их получения, фармацевтическая композиция и их применение в качестве противовоспалительных и анальгетических средств |
| CN107739316B (zh) * | 2017-11-14 | 2020-07-14 | 中国医科大学 | 一种溴代酪氨酸生物碱类化合物及其制备方法和用途 |
| RU2697414C1 (ru) * | 2018-05-11 | 2019-08-14 | Общество с ограниченной ответственностью "АЙ БИ ДИ Терапевтикс" | Новый антагонист тахикининовых рецепторов и его применение |
-
2018
- 2018-05-11 RU RU2018117463A patent/RU2697414C1/ru active
-
2019
- 2019-05-07 KR KR1020207035511A patent/KR20210008061A/ko unknown
- 2019-05-07 SG SG11202011189TA patent/SG11202011189TA/en unknown
- 2019-05-07 MA MA052582A patent/MA52582A/fr unknown
- 2019-05-07 IL IL278603A patent/IL278603B2/en unknown
- 2019-05-07 JP JP2021513748A patent/JP7301954B2/ja active Active
- 2019-05-07 CA CA3099849A patent/CA3099849A1/en active Pending
- 2019-05-07 MX MX2020012035A patent/MX2020012035A/es unknown
- 2019-05-07 WO PCT/RU2019/050060 patent/WO2019216795A1/ru active Application Filing
- 2019-05-07 EP EP19799411.4A patent/EP3792247A4/en active Pending
- 2019-05-07 GE GEAP201915511A patent/GEP20237454B/en unknown
- 2019-05-07 CU CU2020000083A patent/CU24662B1/es unknown
- 2019-05-07 US US17/054,686 patent/US11414377B2/en active Active
- 2019-05-07 EA EA202092712A patent/EA202092712A1/ru unknown
- 2019-05-07 CN CN201980044155.6A patent/CN112384495B/zh active Active
- 2019-05-07 AU AU2019267188A patent/AU2019267188B2/en active Active
-
2020
- 2020-11-09 CL CL2020002908A patent/CL2020002908A1/es unknown
- 2020-11-11 PH PH12020551928A patent/PH12020551928A1/en unknown
- 2020-11-11 ZA ZA2020/07027A patent/ZA202007027B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021523235A (ja) | 2021-09-02 |
| CA3099849A1 (en) | 2019-11-14 |
| IL278603B2 (en) | 2024-03-01 |
| BR112020022807A2 (pt) | 2021-02-02 |
| IL278603A (es) | 2021-03-01 |
| CU20200083A7 (es) | 2021-06-08 |
| RU2697414C1 (ru) | 2019-08-14 |
| CL2020002908A1 (es) | 2021-03-26 |
| CN112384495B (zh) | 2023-07-18 |
| GEP20237454B (en) | 2023-01-10 |
| CN112384495A (zh) | 2021-02-19 |
| AU2019267188B2 (en) | 2024-02-15 |
| IL278603B1 (en) | 2023-11-01 |
| ZA202007027B (en) | 2022-08-31 |
| EA202092712A1 (ru) | 2021-02-17 |
| PH12020551928A1 (en) | 2021-06-14 |
| KR20210008061A (ko) | 2021-01-20 |
| JP7301954B2 (ja) | 2023-07-03 |
| CU24662B1 (es) | 2023-05-11 |
| SG11202011189TA (en) | 2020-12-30 |
| WO2019216795A1 (ru) | 2019-11-14 |
| MA52582A (fr) | 2021-03-17 |
| US11414377B2 (en) | 2022-08-16 |
| AU2019267188A1 (en) | 2020-11-26 |
| US20210070692A1 (en) | 2021-03-11 |
| EP3792247A4 (en) | 2022-01-12 |
| EP3792247A1 (en) | 2021-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2019007696A1 (en) | NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS | |
| JP5658272B2 (ja) | Ｃｃｒ２の新規アンタゴニスト及びこれらの使用 | |
| TW200626563A (en) | Substituted piperazines as CB1 antagonists | |
| JP5721242B2 (ja) | 新規ｃｃｒ２アンタゴニスト | |
| PE20091225A1 (es) | Derivados de quinolina como antagonistas del receptor p2x7 | |
| IL177291A0 (en) | Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists | |
| NO20083500L (no) | 1,4-disubstituerte 3-cyano-pyridonderivater og deres anvendelse som positiv-allosteriske modulatorer av mGluR2 receptorer | |
| TN2009000524A1 (en) | Novel dicarboxylic acid derivatives as s1p1 receptor agonists | |
| EA201200876A1 (ru) | Новые антагонисты рецептора ccr2 и их применение | |
| JP5636094B2 (ja) | Ｃｃｒ２受容体アンタゴニスト | |
| EA200901160A1 (ru) | Производные 3-циано-4-(4-тетрагидропиранфенил)пиридин-2-она | |
| US20160367525A1 (en) | Uses of sesquiterpene lactone compounds and their derivatives in drugs preparation | |
| JP2014520826A (ja) | 新規かつ選択的なｃｃｒ２拮抗薬 | |
| MX2021014113A (es) | Derivados de aminoquinazolina como inhibidores del purinoreceptor 3 de p2x (p2x3). | |
| MX2010000334A (es) | Piperazinas sustituidas como antagonistas de cannabinoides 1. | |
| PH12020551928A1 (en) | Novel modulator of metabotropic and ionotropic transmembrane receptors and use thereof | |
| UA108765C2 (xx) | Дизаміщені тетрагідрофуранільні сполуки як антагоністи брадикінінового рецептора в1 | |
| EA202092976A1 (ru) | Устойчивые фармацевтические композиции для дозированных ингаляторов под давлением | |
| EA201001645A1 (ru) | Хинуклидиновые производные в качестве антагонистов мускаринового м3 рецептора | |
| MY195576A (en) | Novel Amino-Imidazopyridine Derivatives as Janus Kinase Inhibitors and Pharmaceutical use Thereof | |
| KR20150070290A (ko) | Trp 채널 길항제로서의 6-아미노인돌 유도체 | |
| MX2007011079A (es) | Derivados de diaza-espiro-[4-4]-nonano como antagonistas de la neurocinina (nk1). | |
| MX2023005805A (es) | Derivados de 4-aminas de (aza)quinolina como inhibidores del purinorreceptor 3 p2x (p2x3). | |
| WO2011119694A1 (en) | Trpv4 antagonists | |
| MX2021014116A (es) | Derivados de piridopirimidinas como inhibidores del purinoreceptor 3 de p2x (p2x3). |